Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors.
<h4>Background</h4>Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct bioenergetic phenotypes, generally enhancing glyc...
Guardado en:
Autores principales: | Nívea Dias Amoêdo, Mariana Figueiredo Rodrigues, Paula Pezzuto, Antonio Galina, Rodrigo Madeiro da Costa, Fábio Ceneviva Lacerda de Almeida, Tatiana El-Bacha, Franklin David Rumjanek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4e7cc3383a44c499d8bda56dfaf5965 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors
por: Madhumanti Barman, et al.
Publicado: (2021) -
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
por: Ververis K, et al.
Publicado: (2013) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
por: Tandon N, et al.
Publicado: (2016) -
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
por: Jay H. Kalin, et al.
Publicado: (2018) -
Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Iason Psilopatis, et al.
Publicado: (2021)